Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells

International Journal of Cancer

Volumn 120, Issue 9, 2007, Pages 1855-1862

  Tai, Mei Hui ^a   Upham, Brad L ^b   Olson, Lawrence Karl ^a   Tsao, Ming Sound ^c,d   Reed Jr , Donald N ^b   Trosko, James E ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Connexin 36; Gap junction; PAH; Telomerase

Indexed keywords

1 METHYLANTHRACENE; 2 METHYLANTHRACENE; ANTHRACENE DERIVATIVE; ARACHIDONIC ACID; CIGARETTE SMOKE; CYCLIC AMP; DYE; FORSKOLIN; GAP JUNCTION PROTEIN; GROWTH FACTOR; HORMONE; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; EPIGENETICS; EPITHELIUM CELL; GAP JUNCTION; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-METHYL-3-ISOBUTYLXANTHINE; ANTHRACENES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE; CONNEXIN 43; CONNEXINS; EPITHELIAL CELLS; FORSKOLIN; GAP JUNCTIONS; HUMANS; PANCREATIC DUCTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKE; TELOMERASE; TOBACCO;

EID: 33947214073     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22530     Document Type: Article

References (79)

1. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003;95:948-60.
2. Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, et al. Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 2002;15;677-85.
3. Ahlgren JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996;23:241-50.
4. Nilsen TI, Vatten LJ. A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trondelag, Norway. Cancer Causes Control 2000;11:645-52.
5. Li D. Molecular epidemiology of pancreatic cancer. Cancer J 2001;7:259-65.
6. Trede M, Richter A, Wendl K. Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 2001;81:595-610.
7. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003;27:87-93.
8. Lynch HT, Brand RE, Lynch JF, Fusaro RM, Kern SE. Hereditary factors in pancreatic cancer. J Hepatobiliary Pancreat Surg 2002;9: 12-31.
9. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001;21:7-25.
10. Silverman DT, Hoover RN, Brown LM, Swanson GM, Schiffman M, Greenberg RS, Hayes RB, Lillemoe KD, Schoenberg JB, Schwartz AG, Liff J, Pottern LM, et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology 2003;14:45-54.
11. Rubin H. Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis. Oncogene 2002;21:7392-411.
12. Thilly WG. Have environmental mutagens caused oncomutations in people? Nat Genet 2003;34:255-9.
13. Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, Rimm EB, Willett WC, Speizer FE. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156:2255-60.
14. Potter VR. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. Br J Cancer 1978;38:1-23.
15. Trosko JE. The role of stem cells and gap junctional intercellular communication in carcinogenesis. J Biochem Mol Biol 2003;36:43-8.
16. Ruch RJ, Trosko JE. Gap-junction communication in chemical carcinogenesis. Drug Metab Rev 2001;33:117-24.
17. Subarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003;20:237-50.
18. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 (Suppl):245-54.
19. Barcellos-Hoff MH. It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment. J Mammary Gland Biol Neoplasia 2001;6:213-21.
20. Klaunig JE, Kamendulis LM, Xu Y. Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol 2000;19:543-55.
21. Trosko JE, Chang CC. Nongenotoxic mechanisms in carcinogenesis: role of inhibited intercellular communication. In: Hart RW, Hoerger FD, eds. Banbury Report 31: carcinogen risk assessment: new directions in the quantitative and qualitative assessment aspects. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1988.139-70.
22. Terzaghi M, Nettesheim P. Dynamics of neoplastic development in carcinogen-exposed tracheal mucosa. Cancer Res 1979;39:4003-10.
23. Ullrich RL. The rate of progression of radiation-transformed mammary epithelial cells is enhanced after low-dose-rate neutron irradiation. Radiat Res 1986;105:68-75.
24. Kamiya K, Yasukawa-Barnes J, Mitchen JM, Gould MN, Clifton KH. Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. Proc Natl Acad Sci USA 1995;92:1332-6.
25. Mehta PP, Bertram JS, Loewenstein WR. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 1986;44:187-96.
26. Enomoto T, Yamasaki H. Lack of intercellular communication between chemically transformed and surrounding nontransformed BALB/c 3T3 cells. Cancer Res 1984;44:5200-3.
27. Trosko JE, Chang CC. Adaptive and nonadaptive consequences of chemical inhibition of intercellular communication. Pharmacol Rev 1984;36:137S-144S.
28. Loewenstein WR, Rose B. The cell-cell channel in the control of growth. Semin Cell Biol 1992;3:59-79.
29. Trosko JE, Chang CC. Role of stem cells and gap junctional intercellular communication in human carcinogenesis. Radiat Res 2001; 155:175-80.
30. Trosko JE, Chang CC, Madhukar BV, Dupont E. Oncogenes, tumor suppressor genes and intercellular communication in the 'Oncogeny as partially blocked ontogeny' hypothesis. In: Iversen OH, ed. New frontiers in cancer causation. Washington, DC: Taylor and Francis, 1993.181-97.
31. Markert CL. Neoplasia: a disease of cell differentiation. Cancer Res 1968;28:1908-14.
32. Pierce GB. Neoplasms, differentiations and mutations. Am J Pathol 1974;77:103-18.
33. Till JE. Stem cells in differentiation and neoplasia. J Cell Physiol Suppl 1982;1:3-11.
34. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by E6E7 gene of human papilloma virus 16. Am J Pathol 1996;148:1763-70.
35. Tai M-H, Chang CC, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26:495-502.
36. Askari MDF, Tsao M-S, Schuller HM, The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulateds proliferation of immortalized human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 2005;131:639-48.
37. Severson RF, Snook ME, Higman HC, Chortyk OT, Akin FJ. Isolation, identification, and quantification of polynuclear aromatic hydrocarbons in tobacco smoke. In: Freudenthal RI, Jones PW, eds. Carcinogenesis-a comprehensive survey, vol. 1: polynuclear aromatic hydrocarbons: chemistry, metabolism, and carcinogenesis. New York: Raven Press, 1976.253-70.
38. El-Fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 1987;168:422-30.
39. Trosko JE, Chang CC, Wilson MR, Upham B, Hayashi T, Wade M. Gap junctions and the regulation of cellular functions of stem cells during development and differentiation. Methods 2000;20:245-64.
40. Weis LM, Rummel AM, Masten SJ, Trosko JE, Upham BL. Bay or baylike regions of polycyclic aromatic hydrocarbons were potent inhibitors of gap junctional intercellular communication. Environ Health Perspect 1998;106:17-22.
41. Upham BL, Yao JJ, Trosko JE, Masten SJ. Determination of the efficacy of ozone treatment systems using a gap junction intercellular communication bioassay. Environ Sci Technol 1995;29:2923-8.
42. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1978;76:4350-4.
43. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
44. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996;380:79-82.
45. McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol 2003;77:9852-61.
46. Hoffmann D, Schmeltz SS, Hecht SS, Wynder EL. Tobacco carcinogenesis. In: Gelboin HV, Ts'o PO, eds. Polycyclic aromatic hydrocarbonds and cancer, vol. 1: environment, chemistry, and metabolism. San Diego: Academic Press, 1978.85-117.
47. Van Duuren BL, Sivak A, Langseth L. The tumor-promoting activity of tobacco leaf extract and whole cigarette tar. Br J Cancer 1967;21: 460-3.
48. Van Duuren BL, Sivak A, Katz C, Melchionne S. Cigarette smoke carcinogenesis: importance of tumor promoters. J Natl Cancer Inst 1971;47:235-40.
49. Bock FG. Tumor promoters in tobacco and cigarette-smoke condensate. J Natl Cancer Inst 1972;48:1849-53.
50. Wynder EL, Hoffmann D. Tobacco and tobacco smoke. Semin Oncol 1976;3:5-15.
51. Weis LM, Rummel AM, Masten SJ, Trosko JE, Upham BL. Bay or baylike regions of polycyclic aromatic hydrocarbons were potent inhibitors of gap junctional intercellular communication. Environ Health Perspect 1998;106:17-22.
52. Upham BL, Weis LM, Trosko JE. Modulated gap junctional intercellular communication as a biomarker of PAH epigenetic toxicity: structure-function relationship. Environ Health Perspect 1998;106: 975-81.
53. Blaha L, Kapplova P, Vondracek J, Upham B, Machala M. Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicol Sci 2002;65:43-51.
54. Tithof PK, Elgayyar M, Cho Y, Guan W, Fisher AB, Peters-Golden M. Polycyclic aromatic hydrocarbons present in cigarette smoke cause endothelial cell apoptosis by a phospholipase A2-dependent mechanism. FASEB J 2002;16:1463-4.
55. Upham B, Davis JM, Trosko JE, Schwartz KA. Polycyclic aromatic hydrocarbons with bay-like structures inhibited gap junctional intercellular communication in neonatal rat cardiomyocytes and caused asynchronous beating. Toxicol Sci 2002;66:1410 (abstract).
56. Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P. β-Cell crosstalk: a further dimension in the stimulus-secretion coupling of glucose-induced insulin release. Diabetes Metab 2002;28: 3S45-3S53.
57. 2+ oscillations and insulin secretion in MIN6 cells. Diabetes 2003;52:417-24.
58. Calabrese A, Guldenagel M, Charollais A, Mas C, Caton D, Bauquis J, Serre-Beinier V, Caille D, Sohl G, Teubner B, Le Gurun S, Trovato-Salinaro A, et al. Cx36 and the function of endocrine pancreas. Cell Commun Adhes 2001;8:387-91.
59. Serre-Beinier V, Le Gurun S, Belluardo N, Trovato-Salinaro A, Charollais A, Haefliger JA, Condorelli DF, Meda P. Cx36 preferentially connects β-cells within pancreatic islets. Diabetes 2000;49: 727-34.
60. Pfeffer F, Koczan D, Adam U, Benz S, von Dobschuetz E, Prall F, Nizze H, Thiesen HJ, Hopt UT, Lobler M. Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas 2004;29:284-90.
61. Tai M-H, Madhukar BV, Olson LK, Linning KD, VanCamp L, Tsao MS, Trosko JE Characterization of gap junctional intercellular communication in immortalized human ductal epithelial cells with stem cell characteristics. Pancreas 2003;26:e18-e26.
62. Blaha L, Trosko JE, Upham BL. The role of phospholipases in the inhibition of gap junction communication and the activation of MAPK by specific isomers of methylated anthracenes. Toxocol Sci Suppl 2006;90:961 (abstract).
63. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994;59:307-15.
64. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-20.
65. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994;68:3410-4.
66. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992;27:375-82.
67. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998;95:90-2.
68. Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R. Telomerase activity in normal human endothelial cells. Anticancer Res 1997;17:827-32.
69. Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997;94:13677-82.
70. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
71. Sun W, Kang KS, Morita I, Trosko JE, Chang CC. High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization. Cancer Res 1999;59: 6118-23.
72. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
73. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
74. Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 1998;91:3255-62.
75. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
76. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
77. Cerezo A, Stark HJ, Moshir S, Boukamp P. Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 2003;121:110-9.
78. Lopatina NG, Poole JC, Saldanha SN, Hansen NJ, Key JS, Pita MA, Andrews LG, Tollefsbol TO. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem Biophys Res Commun 2003;306: 650-9.
79. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2.